(no title)
mikequinlan | 8 months ago
>But patients in the trial had to stay on drugs to prevent the immune system from destroying the new cells. Suppressing the immune system, he said, increases the risk of infections and, over the long term, can increase the risk of cancer.
>“The argument is this immunosuppression is not as dangerous as what we typically use for kidneys, hearts and lungs, but we won’t know that definitely for many years,” Dr. Hirsch said.
>Patients may have to take the immunosuppressant drugs for the rest of their lives, the Vertex spokeswoman said.
https://www.nytimes.com/2025/06/20/health/diabetes-cure-insu...
ink_13|8 months ago
nmehner|8 months ago
From what I understand from the study the aim is to show that mass producing islet cells from stem cells is possible. Previously those where extracted from pancreases from dead people.
Having cells extracted from your own body has the advantage that there are a lot of they are not rejected by the immune system.
The reason the immune suppression is still needed is the cause of type 1 diabetes: It is a auto immune disease where the body attacks its own islet cells.
But this a specific immune reaction which could be easier to prevent than the generic rejection of cells from a different body. But this is not what this approach is trying to do for now.
This study just wants to show: This approach of creating islet cells work and it is worth trying to do a bigger more expensive study that can produce statistically relevant results.
"Curing" type 1 diabetis is still years off and that requires the immune issue to be solved as well.
aaron695|8 months ago
[deleted]
etaioinshrdlu|8 months ago
gsf_emergency_2|8 months ago
The hope is that patient-derived cells will eventually be possible (whether the margins are attractive or not)